References
1. Kessing LV, Bauer M, Nolen WA, Severus E, Goodwin GM, Geddes J.
Effectiveness of maintenance therapy of lithium vs other mood
stabilizers in monotherapy and in combinations: a systematic review of
evidence from observational studies. Bipolar Disord 2018; 20: 419-31.
2. BALANCE- investigators-collaborators, Geddes JR, Goodwin GM, Rendell
J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E.
Lithium plus valproate combination therapy versus monotherapy for
relapse prevention in bipolar I disorder (BALANCE): a randomised
open-label trial. Lancet 2010; 375: 385-95.
3. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR.
Lithium toxicity profile: a systematic review and meta-analysis. Lancet
2012; 379: 721-8.
4. Ott M, Stegmayr B, Salander Renberg E, Werneke U. Lithium
intoxication: Incidence, clinical course and renal function - a
population-based retrospective cohort study. J Psychopharmacol 2016; 30:
1008-19.
5. Vodovar D, Beaune S, Langrand J, Vicaut E, Labat L, Megarbane B.
Assessment of Extracorporeal Treatments in Poisoning criteria for the
decision of extracorporeal toxin removal in lithium poisoning. Br J Clin
Pharmacol 2020; 86: 560-68.
6. Vodovar D, El Balkhi S, Curis E, Deye N, Megarbane B. Lithium
poisoning in the intensive care unit: predictive factors of severity and
indications for extracorporeal toxin removal to improve outcome. Clin
Toxicol (Phila) 2016; 54: 615-23.
7. Baird-Gunning J, Lea-Henry T, Hoegberg LCG, Gosselin S, Roberts DM.
Lithium Poisoning. J Intensive Care Med 2017; 32: 249-63.
8. Verbov JL, Phillips JD, Fife DG. A case of lithium intoxication.
Postgrad Med J 1965; 41: 190-2.
9. Schou M. Long-lasting neurological sequelae after lithium
intoxication. Acta Psychiatr Scand 1984; 70: 594-602.
10. Adityanjee. The syndrome of irreversible lithium effectuated
neurotoxicity. J Neurol Neurosurg Psychiatry 1987; 50: 1246-7.
11. Adityanjee, Munshi KR, Thampy A. The syndrome of irreversible
lithium-effectuated neurotoxicity. Clin Neuropharmacol 2005; 28: 38-49.
12. Donaldson IM, Cuningham J. Persisting neurologic sequelae of lithium
carbonate therapy. Arch Neurol 1983; 40: 747-51.
13. Kores B, Lader MH. Irreversible lithium neurotoxicity: an overview.
Clin Neuropharmacol 1997; 20: 283-99.
14. Roy M, Stip E, Black DN, Lew V, Langlois R. Neurological sequelae
following acute lithium poisoning - Review of the literature. Can J
Psychiatry 1999; 44: 671-79.
15. Verdoux H, Bourgeois M. [Irreversible neurologic sequelae caused
by lithium]. Encephale 1991; 17: 221-4.
16. Cohen WJ, Cohen NH. Lithium carbonate, haloperidol, and irreversible
brain damage. JAMA 1974; 230: 1283-87.
17. Tournier M, Neumann A, Pambrun E, Weill A, Chaffiol JP, Alla F,
Begaud B, Maura G, Verdoux H. Conventional mood stabilizers and/or
second-generation antipsychotic drugs in bipolar disorders: A
population-based comparison of risk of treatment failure. J Affect
Disord 2019; 257: 412-20.
18. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA
statement. PLoS Med 2009; 6: e1000097.
19. Decker BS, Goldfarb DS, Dargan PI, Friesen M, Gosselin S, Hoffman
RS, Lavergne V, Nolin TD, Ghannoum M, Workgroup E. Extracorporeal
Treatment for Lithium Poisoning: Systematic Review and Recommendations
from the EXTRIP Workgroup. Clin J Am Soc Nephrol 2015; 10: 875-87.
20. Pheterson AD, Miller L, Fox CF, Estroff TW, Sweeney DR. Multifocal
neurological impairment caused by infection-induced rise in blood
lithium and amitriptyline. Int J Psychiatry Med 1986; 16: 257-62.
21. Yoshimoto Y. A case of lithium intoxication with downbeat vertical
nystagmus. Auris Nasus Larynx 1987; 14: 71-5.
22. Lal V, Sardana V, Thussu A, Sawhney I, Prabhakar S. Cerebellar
degeneration following neuroleptic malignant syndrome. Postgrad Med J
1997; 73: 735-36.
23. Epstein Y, Albukrek D, Kalmovitc B, Moran DS, Shapiro Y. Heat
intolerance induced by antidepressants. Ann N Y Acad Sci 1997; 813:
553-8.
24. Muthane UB, Prasad BN, Vasanth A, Satishchandra P. Tardive
Parkinsonism, orofacial dyskinesia and akathisia following brief
exposure to lithium carbonate. J Neurol Sci 2000; 176: 78-9.
25. Ozsoy S, Basturk M, Esel E. Cerebellar syndrome in a patient with
pneumonia under lithium treatment: A case report. Prog
Neuropsychopharmacol Biol Psychiatry 2006; 30: 1532-4.
26. Araujo LC, Nery-Fernandes F, Quarantini LC, Miranda-Scippa A.
Persistent neurotoxicity secondary to lithium use: case report. Revista
Brasileira De Psiquiatria 2006; 28: 163-63.
27. Niethammer M, Ford B. Permanent lithium-induced cerebellar toxicity:
three cases and review of literature. Mov Disord 2007; 22: 570-3.
28. Tharoor H, Deora S, Chauhan A, Sharma PSVN. Lithium-neuroleptic
combination leading to permanent neurological sequelae? German Journal
of Psychiatry 2007; 10: 18-20.
29. de Cerqueira ACR, dos Reis MC, Novis FD, Bezerra JMF, de Magalhães
GC, Rozenthal M, Nardi AE. Cerebellar degeneration secondary to acute
lithium carbonate intoxication. Arquivos de Neuro-Psiquiatria 2008; 66:
578-80.
30. Keltner NL, Grant JS. Irreversible lithium-induced neuropathy: Two
cases. Pers Psychiatr Care 2008; 44: 290-93.
31. Fischera M, Anneken K, Evers S, Kloska S, Husstedt IW. Cerebellar
atrophy after long-term treatment with low-dose lithium.
Pharmacopsychiatry 2009; 42: 125-26.
32. Porto FHG, Leite MAA, Fontenelle LF, Marrocos RP, Szczerback NF, de
Freitas MRG. The Syndrome of Irreversible Lithium-Effectuated
Neurotoxicity (SILENT): One-year follow-up of a single case. J Neurol
Sci 2009; 277: 172-73.
33. Mazzini L, Oggioni GD, Nasuelli N, Servo S, Testa L, Monaco F.
Disabling Parkinsonism following brief exposure to lithium carbonate in
amyotrophic lateral sclerosis. J Neurol 2011; 258: 333-4.
34. Banwari G, Chaudhary P, Panchmatia A, Patel N. Persistent cerebellar
dysfunction following acute lithium toxicity: A report of two cases.
Indian J Pharmacol 2016; 48: 331-3.
35. Hallab B, Agoub M, Battas O. Lithium-neuroleptic combination leading
to permanent neurological sequelae (case report). Annales
Medico-Psychologiques 2017; 175: 862-64.
36. Hallab B, Hallab S, Battas O, Agoub M. Syndrome of irreversible
lithium-effectuated neuro-toxicity or SILENT: A case report. Therapie
2017; 72: 403-07.
37. Rossi FH, Rossi EM, Hoffmann M, Liu W, Cruz RR, Antonovich N, Rezaei
A, Gonzalez E, Franco MC, Estevez A, Thomas F. Permanent Cerebellar
Degeneration After Acute Hyperthermia with Non-toxic Lithium Levels: a
Case Report and Review of Literature. Cerebellum 2017; 16: 973-78.
38. Silva AL, Ourique C, Martins F, Frioes F. Syndrome of Irreversible
Lithium-Effectuated NeuroToxicity. Acta Medica Portuguesa 2017; 30:
151-53.
39. Fountoulakis KN, Tegos T, Kimiskidis V. Lithium monotherapy-induced
tardive dyskinesia. J Affect Disord 2019; 244: 78-79.
40. Baker PC, Price TR, Allen CD. Brain stem and cerebellar dysfunction
with Legionnaires’ disease. J Neurol Neurosurg Psychiatry 1981; 44:
1054-6.
41. Habib M, Khalil R, le Pensec-Bertrand D, Ali-Cherif A, Bongrand MC,
Crevat A. [Persistent neurological syndrome after treatment with
lithium salts. Toxicity of the lithium-neuroleptic combination?]. Rev
Neurol (Paris) 1986; 142: 61-4.
42. Servant D, Gaudet Y, Danel T, Goudemand M, Petit H. [Persistent
cerebellar syndrome following treatment with lithium salts]. Presse
Med 1987; 16: 312.
43. Pelletier J, Habib M, Pellissier JF, Crevat A, Khalil R.
[Neurologic sequelae of the neuroleptics-lithium combination: role of
hyperthermia]. Rev Med Interne 1991; 12: 187-91.
44. Merle C, Sotto A, Galland MC, Jourdan E, Jourdan J. Persistent
cerebellar syndrome after lithium and neuroleptic therapy. Therapie
1998; 53: 511-13.
45. Biscof F, Melms A. Persistent cerebellar deterioration in a patient
with lobar pneumonia. Eur Psychiatry 1999; 14: 175–76.
46. Verdoux H, Bourgeois ML. A case of lithium neurotoxicity with
irreversible cerebellar syndrome. J Nerv Ment Dis 1990; 178: 761-2.
47. Gille M, Ghariani S, Pieret F, Delbecq J, Depre A, Saussu F, de
Barsy T. [Acute encephalomyopathy and persistent cerebellar syndrome
after lithium salt and haloperidol poisoning]. Rev Neurol (Paris)
1997; 153: 268-70.
48. Verdoux H, Pambrun E, Cortaredona S, Coldefy M, Le Neindre C,
Tournier M, Verger P. Geographical disparities in prescription practices
of lithium and clozapine: a community-based study. Acta Psychiatr Scand
2016; 133: 470-80.
49. Bramness JG, Weitoft GR, Hallas J. Use of lithium in the adult
populations of Denmark, Norway and Sweden. J Affect Disord 2009; 118:
224-8.
50. Juul-Jensen P, Schou M. Letter: Permanent brain damage after lithium
intoxication. Br Med J 1973; 4: 673.
51. Zingraff J, Jungers P, Drueke T, Man NK, Crosnier J. [Accidental
lithium poisoning in a patient with chronic hemodialysis]. Nouv Presse
Med 1975; 4: 3181.
52. Izzo KL, Brody R. Rehabilitation in lithium toxicity: case report.
Arch Phys Med Rehabil 1985; 66: 779-82.
53. Heim J, Pinel JF, Allannic H, Ferrand P, Sabouraud O, Lorcy Y. [A
case of permanent neurological sequelae by lithium intoxication during a
thyrotoxicosis (author’s transl)]. Sem Hop 1981; 57: 1349-52.
54. Schneider JA, Mirra SS. Neuropathologic correlates of persistent
neurologic deficit in lithium intoxication. Ann Neurol 1994; 36: 928-31.
55. van Gaalen J, Kerstens FG, Maas R, Harmark L, van de Warrenburg BPC.
Drug-Induced Cerebellar Ataxia: A Systematic Review. Cns Drugs 2014; 28:
1139-53.
56. Goldman SA. FDA MedWatch report: Lithium and neuroleptics in
combination: The spectrum of neurotoxicity. Psychopharmacol Bull 1996;
32: 299-309.
57. Verdoux H, Gonzales B, Takei N, Bourgeois M. A survey of prescribing
practice of antipsychotic maintenance treatment for manic-depressive
outpatients. J Affect Disord 1996; 38: 81-7.
58. Naramoto A, Koizumi N, Itoh N, Shigematsu H. An autopsy case of
cerebellar degeneration following lithium intoxication with neuroleptic
malignant syndrome. Acta Pathol Jpn 1993; 43: 55-8.
59. Lecamwasam D, Synek B, Moyles K, Ghose K. Chronic lithium
neurotoxicity presenting as parkinsons-disease. Int Clin Psychopharmacol
1994; 9: 127-29.
60. Ferbert A, Czernik A. [Persistent cerebellar syndrome following
lithium poisoning]. Nervenarzt 1987; 58: 764-70.
61. Peiffer J. Clinical and neuropathological aspects of long-term
damage to the central nervous system after lithium medication. Arch
Psychiatr Nervenkr (1970) 1981; 231: 41-60.
62. Tesio L, Porta GL, Messa E. Cerebellar syndrome in lithium
poisoning: a case of partial recovery. J Neurol Neurosurg Psychiatry
1987; 50: 235.
63. Schou M. Is there a lithium withdrawal syndrome? An examination of
the evidence. Br J Psychiatry 1993; 163: 514-8.
64. Goodwin GM. Recurrence of mania after lithium withdrawal.
Implications for the use of lithium in the treatment of bipolar
affective disorder. Br J Psychiatry 1994; 164: 149-52.
65. Siskind D, Honer WG, Clark S, Correll CU, Hasan A, Howes O, Kane JM,
Kelly DL, Laitman R, Lee J, MacCabe JH, Myles N, Nielsen J, Schulte PF,
Taylor D, Verdoux H, Wheeler A, Freudenreich O. Consensus statement on
the use of clozapine during the COVID-19 pandemic. J Psychiatry Neurosci
2020; 45: 222-23.
66. Verdoux H, Quiles C, de Leon J. Clinical determinants of fever in
clozapine users and implications for treatment management: A narrative
review. Schizophr Res 2019; 211: 1-9.
67. de Leon J, Ruan CJ, Schoretsanitis G, De Las Cuevas C. A Rational
Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and
Clinical Pharmacopsychology. Psychother Psychosom 2020: 1-15.
68. de Leon J, Sanz EJ, Noren GN, De Las Cuevas C. Pneumonia may be more
frequent and have more fatal outcomes with clozapine than with other
second-generation antipsychotics. World Psychiatry 2020; 19: 120-21.
69. Vodovar D, Megarbane B. Prognosis and outcome of severe lithium
poisoning. J Psychopharmacol 2017; 31: 1274-77.
70. Kessing LV, Gerds TA, Knudsen NN, Jorgensen LF, Kristiansen SM,
Voutchkova D, Ernstsen V, Schullehner J, Hansen B, Andersen PK, Ersboll
AK. Association of Lithium in Drinking Water With the Incidence of
Dementia. JAMA Psychiatry 2017; 74: 1005-10.
71. Velosa J, Delgado A, Finger E, Berk M, Kapczinski F, de Azevedo
Cardoso T. Risk of dementia in bipolar disorder and the interplay of
lithium: a systematic review and meta-analyses. Acta Psychiatr Scand
2020.